Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3477)
All Articles published online
|
Aug 15, 2012 (publication date) through Nov 2, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Dijk PRV, Logtenberg SJ, Groenier KH, Haveman JW, Kleefstra N, Bilo HJ. Complications of continuous intraperitoneal insulin infusion with an implantable pump. World J Diabetes 2012; 3(8): 142-148 [PMID: 22912916 DOI: 10.4239/wjd.v3.i8.142] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v3/i8/142.htm |
| Number | Citing Articles |
| 1 |
Siang Ing Lee, Parth Narendran. Intraperitoneal insulin therapy for a patient with type 1 diabetes with insulin injection site inflammation. BMJ Case Reports 2014; : bcr2014205278 doi: 10.1136/bcr-2014-205278
|
| 2 |
Justin M. Gregory, Alan D. Cherrington, Daniel J. Moore. The Peripheral Peril: Injected Insulin Induces Insulin Insensitivity in Type 1 Diabetes. Diabetes 2020; 69(5): 837 doi: 10.2337/dbi19-0026
|
| 3 |
Marga Giménez, Sanjay Purkayajtha, Vanessa Moscardó, Ignacio Conget, Nick Oliver. Intraperitoneal insulin therapy in patients with type 1 diabetes. Does it fit into the current therapeutic arsenal?. Endocrinología, Diabetes y Nutrición 2018; 65(3): 182 doi: 10.1016/j.endinu.2018.01.001
|
| 4 |
Marga Giménez, Sanjay Purkayajtha, Vanessa Moscardó, Ignacio Conget, Nick Oliver. Intraperitoneal insulin therapy in patients with type 1 diabetes. Does it fit into the current therapeutic arsenal?. Endocrinología, Diabetes y Nutrición (English ed.) 2018; 65(3): 182 doi: 10.1016/j.endien.2018.03.007
|
| 5 |
Hyunjoo J. Lee, Nakwon Choi, Eui-Sung Yoon, Il-Joo Cho. MEMS devices for drug delivery. Advanced Drug Delivery Reviews 2018; 128: 132 doi: 10.1016/j.addr.2017.11.003
|
| 6 |
Jia He, Eric Renard, Peter Lord, Don Cohen, Bing Gu, Xiaoyi Wang, Gowtham Yenduri, Diane J. Burgess. Strategies for extended lifetime of implantable intraperitoneal insulin catheters. Journal of Controlled Release 2022; 341: 487 doi: 10.1016/j.jconrel.2021.11.038
|
| 7 |
William V. Tamborlane, Miladys M. Palau‐Collazo. International Textbook of Diabetes Mellitus. 2015; : 765 doi: 10.1002/9781118387658.ch51
|
| 8 |
Murugan Prasathkumar, Robert Becky, Salim Anisha, Chenthamara Dhrisya, Subramaniam Sadhasivam. Evaluation of hypoglycemic therapeutics and nutritional supplementation for type 2 diabetes mellitus management: An insight on molecular approaches. Biotechnology Letters 2022; 44(2): 203 doi: 10.1007/s10529-022-03232-3
|
| 9 |
Melanie R. Nilsson. Insulin amyloid at injection sites of patients with diabetes. Amyloid 2016; 23(3): 139 doi: 10.1080/13506129.2016.1179183
|
| 10 |
P.R. van Dijk, S.J.J. Logtenberg, R.O.B. Gans, H.J.G. Bilo, N. Kleefstra. Intraperitoneal insulin infusion: treatment option for type 1 diabetes resulting in beneficial endocrine effects beyond glycaemia. Clinical Endocrinology 2014; 81(4): 488 doi: 10.1111/cen.12546
|
| 11 |
Rosa Garcia-Verdugo, Michael Erbach, Oliver Schnell. A New Optimized Percutaneous Access System for CIPII. Journal of Diabetes Science and Technology 2017; 11(4): 814 doi: 10.1177/1932296817694913
|
| 12 |
Keith R. Hildebrand. Drug‐Device Combinations For Chronic Diseases. 2015; : 182 doi: 10.1002/9781119002956.ch07
|
| 13 |
K. T. D. Yeung, M. Reddy, S. Purkayastha. Surgical options for glycaemic control in Type 1 diabetes. Diabetic Medicine 2019; 36(4): 414 doi: 10.1111/dme.13885
|
| 14 |
Mohammad Fakhroleslam, Ramin Bozorgmehry Boozarjomehry. A multi‐objective optimal insulin bolus advisor for type 1 diabetes based on personalized model and daily diet. Asia-Pacific Journal of Chemical Engineering 2021; 16(4) doi: 10.1002/apj.2651
|
| 15 |
Vladimir Aleksandrovich Karpel'ev, Elena Anatol'evna Fedorova, Yury Ivanovich Philippov, Aleksandr Yur'evich Mayorov, Marina Vladimirovna Shestakova. Intraperitoneal insulin infusion: on the way to the artificial pancreas. Diabetes mellitus 2015; 18(3): 32 doi: 10.14341/DM2015332-45
|
| 16 |
Lia Bally, Hood Thabit, Roman Hovorka. Finding the right route for insulin delivery – an overview of implantable pump therapy. Expert Opinion on Drug Delivery 2017; 14(9): 1103 doi: 10.1080/17425247.2017.1267138
|
| 17 |
Jordan Magisson, Aladin Sassi, Aram Kobalyan, Charles-Thibault Burcez, Richard Bouaoun, Michel Vix, Nathalie Jeandidier, Severine Sigrist. A fully implantable device for diffuse insulin delivery at extraperitoneal site for physiological treatment of type 1 diabetes. Journal of Controlled Release 2020; 320: 431 doi: 10.1016/j.jconrel.2020.01.055
|
| 18 |
E. Zini, I. Padrutt, K. Macha, A. Riederer, M. Pesaresi, T.A. Lutz, C.E. Reusch. Use of an implantable pump for controlled subcutaneous insulin delivery in healthy cats. The Veterinary Journal 2017; 219: 60 doi: 10.1016/j.tvjl.2016.12.006
|
| 19 |
Maggie J. Malone-Povolny, Taron M. Bradshaw, Elizabeth P. Merricks, C. Tyler Long, Timothy C. Nichols, Mark H. Schoenfisch. Combination of Nitric Oxide Release and Surface Texture for Mitigating the Foreign Body Response. ACS Biomaterials Science & Engineering 2021; 7(6): 2444 doi: 10.1021/acsbiomaterials.1c00022
|
| 20 |
Swarnali Paul, Shahnaz Begum, Hasan Parvej, Ramkrishna Dalui, Subrata Sardar, Falguni Mondal, Nayim Sepay, Umesh Chandra Halder.
In vitro retardation and modulation of human insulin amyloid fibrillation by Fe3+ and Cu2+ ions. New Journal of Chemistry 2024; 48(7): 3120 doi: 10.1039/D3NJ04431A
|